Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE (WBA)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 10:00:00 pm
78.74 USD   -4.35%
11/11P&G, McDonald's Power Dow Rebound in Sign of Continued Anxiety
DJ
10/15WALGREENS BOOTS ALLIANCE : Buying pressure
10/12RITE AID : Deal Lifts Walgreens Pharmacy
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Walgreens Boots Alliance : Sales Growth Falls Short -- 2nd Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 07:39pm CET

By Kimberly Chin

Walgreens Boots Alliance Inc. said growth in prescription volumes helped lift pharmacy sales in its latest quarter, as the company's integration of Rite Aid stores expanded its foothold in the U.S. prescription market.

Walgreens's share of the U.S. retail prescription market this year has grown to a company record 21.7%, compared with 20.2% in 2017, Walgreens Chief Financial Officer James Kehoe said Thursday, citing data from health-care research firm Iqvia.

For the fourth quarter, Walgreens said it had filled the largest number of prescriptions in its 117-year history, largely because of its retention of many Rite Aid prescription-drug customers after taking over those stores. Walgreens closed a $4.4 billion deal earlier this year to buy more than 1,900 pharmacies from Rite Aid Corp.

Walgreens, based in Deerfield, Ill., said U.S. pharmacy sales rose 17% from the year-earlier quarter while prescriptions filled in comparable stores increased 1.3%. Overall sales rose 11% to $33.44 billion, though analysts had expected Walgreens to report $33.78 billion in sales based on a Refinitiv poll.

The drugstore chain has engaged in several deals and partnerships with the aim of expanding its pharmacy business to become a "health-care destination" for health, beauty and personal care, said Chief Executive Stefano Pessina.

Walgreens reached a deal in September to buy customer files from a group of stores that are part of the Fred's Inc. drugstore chain. This month, Walgreens said it would work with clinical-lab operator LabCorp, known formally as Laboratory Corp. of America Holdings, to open at least 600 LabCorp patient centers at its stores over the next four years. It also reached an agreement with Kroger Co., the nation's largest supermarket chain, to work together to pilot a new store format. The company has also looked to boost its beauty aisles with high-end cosmetics after taking a minority stake in beauty startup Birchbox Inc.

Growth in Walgreens's pharmacy business helped offset weakness in sales of general merchandise and personal-care items. Comparable retail sales in the fourth quarter fell 1.9% from a year earlier in the U.S., and 0.9% in the company's international segment on a constant-currency basis. The company has more than 18,500 stores across 11 countries.

Shares in Walgreens were up 1.5% at $73.40 at midday Thursday.

Net income for the company rose 89% to $1.51 billion, or $1.55 a share. On an adjusted basis, earnings per share came in at $1.48, above the $1.45 expected by analysts.

For the current fiscal year Walgreens forecast earnings growth between 7% and 12% at constant currency rates, and adjusted earnings per share in the range of $6.40 to $6.70. Analysts expect adjusted earnings of $6.45 a share.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
RITE AID CORPORATION -1.44% 0.8944 Delayed Quote.-54.60%
WALGREENS BOOTS ALLIANCE -4.35% 78.74 Delayed Quote.8.43%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
12/14WALGREENS : Launches Flu Index™ for 2018-2019 Season
BU
12/13FRED : Down 23% After Quarterly Results
DJ
12/13AVON PRODUCTS : CFO to Step Down
DJ
12/11WALGREENS BOOTS ALLIANCE : Announces Transfer of Listing of Debt Securities to N..
BU
12/11WALGREENS BOOTS ALLIANCE : Governor Parson Joins Walgreens to Launch Safe Medica..
BU
12/11WALGREENS BOOTS ALLIANCE : Schedules Fiscal 2019 First Quarter Earnings Announce..
BU
12/07WALGREENS BOOTS ALLIANCE : Widespread Popularity of Wearable Devices are Prompti..
PR
12/07Online Push Hurts Kroger's Margins -- WSJ
DJ
12/06WALGREENS BOOTS ALLIANCE, INC. : Entry into a Material Definitive Agreement, Ter..
AQ
12/06Walgreens Launches Next-Day Prescription Home Delivery with FedEx
DJ
More news
Financials ($)
Sales 2019 138 B
EBIT 2019 8 009 M
Net income 2019 5 477 M
Debt 2019 12 909 M
Yield 2019 2,29%
P/E ratio 2019 13,66
P/E ratio 2020 12,49
EV / Sales 2019 0,64x
EV / Sales 2020 0,60x
Capitalization 74 472 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 78,2 $
Spread / Average Target -0,65%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
Richard M. Ashworth President-Operations
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE8.43%74 472
EXPRESS SCRIPTS HOLDING CO31.59%55 382
MCKESSON CORPORATION-25.19%22 793
AMERISOURCEBERGEN-13.99%16 736
CARDINAL HEALTH-18.30%14 915
SUZUKEN CO., LTD.30.98%5 588